GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

The agreement saw Novavax lift the going concern notice it issued in 2023, when the Gaithersburg, Maryland company warned that plunging COVID-19 vaccines sales could push it into bankruptcy.

GAITHERSBURG, Md., Oct. 16, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today ...

Novavax (NASDAQ:NVAX ... led to a sharp rally in the company stock in the previous session. Shares of the Gaithersburg, Maryland-based vaccine maker closed ~19% higher on Wednesday after Jefferies ...

Novavax, Inc. Is a biotechnology company ... The company was founded in 1987 and is headquartered in Gaithersburg, MD.

It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...